Tumor necrosis factor receptor‐2 signaling pathways promote survival of cancer stem‐like CD133(+) cells in clear cell renal carcinoma

Clear cell renal cell carcinoma (ccRCC) contains cancer stem‐like cells (CSCs) that express CD133 (ccRCC‐CD133(+)). CSCs are rarely in cell cycle and, as nonproliferating cells, resist most chemotherapeutic agents. Previously, we reported that tumor necrosis factor receptor‐2 (TNFR2) signaling promo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradley, John R., Wang, Jun, Pacey, Simon, Warren, Anne Y., Pober, Jordan S., Al‐Lamki, Rafia S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003657/
https://www.ncbi.nlm.nih.gov/pubmed/32123862
http://dx.doi.org/10.1096/fba.2019-00071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003657/
https://www.ncbi.nlm.nih.gov/pubmed/32123862
http://dx.doi.org/10.1096/fba.2019-00071

Ejemplares similares